The Pharmacy Times® Immunoglobulins Resource Center is a comprehensive resource for clinical news and expert insights on the use of intravenous immunoglobulin, a product comprised of antibodies administered intravenously.
June 27th 2025
Intravenous immunoglobulin (IVIG) use over an extended period in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) was potentially associated with a reduced incidence of cancer over time, although more research is necessary.
An Overview of Disease Burden Associated With COPD
1.0 Credit / Immunology, Pulmonology/Respiratory
View More
Addressing the Challenges of Treating Moderate to Severe Atopic Dermatitis With Targeted Biologic Therapies in...
1.5 Credits / Allergy, Dermatology, Immunology
View More
Biologic Therapy for the Management of Eosinophilic Esophagitis in Children: The Evolving Treatment Paradigm
1.5 Credits / Gastroenterology, Immunology
View More
Dual Inhibition in the Management of Moderate to Severe Asthma: Selecting the Appropriate Biologic Therapy Bas...
1.5 Credits / Allergy, Pulmonology, Immunology
View More
Treatment Gaps in the Management of Generalized Pustular Psoriasis: Enhancing the Role of Managed Care
1.5 Credits / Dermatology, Immunology
View More
Understanding GOLD Updates and Role of Emerging Biologics in COPD Management
1.0 Credit / Immunology, Pulmonology/Respiratory
View More
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
1.0 Credit / Immunology, Neurology
View More
The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...
2.0 Credits / Human Trafficking, Law
View More
Utilizing the Pharmacist to Improve Patient Outcomes in COPD
1.0 Credit / Immunology, Pulmonology/Respiratory
View More
Foundations in the Management of Eosinophilic Esophagitis: Pathophysiology, Clinical, Economic, and Quality of...
1.0 Credit / Gastroenterology, Immunology
View More
Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape
1.0 Credit / Gastroenterology, Immunology, Rare Diseases
View More
The Evolving Treatment Paradigm for the Management of Eosinophilic Esophagitis and the Future of Oral Therapie...
1.0 Credit / Gastroenterology, Immunology
View More
The Role of the Community Pharmacist in the Management of Eosinophilic Esophagitis
1.0 Credit / Gastroenterology, Immunology
View More
Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies
1.0 Credit / Immunology, Pulmonology/Respiratory
View More
Managed Care Approaches to Individualize Treatment of Hereditary Angioedema
1.0 Credit / Immunology
View More
Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies
1.0 Credit / Law, Pain Management, Opioids
View More
From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care
1.5 Credits / Allergy, Immunology
View More
Balancing the Burden of Moderate to Severe Atopic Dermatitis in Pediatric Patients: Navigating the Use of Targ...
1.5 Credits / Dermatology, Immunology
View More
In-Depth Insights and Application in the Management of Immunoglobulin Therapy
1.0 Credit / Neurology, Immunology
View More
Emerging Biologic Therapy for the Management of COPD: Integrated Approaches to Optimized Care
1.5 Credit / Immunology, Pulmonology/Respiratory
View More
Strategies to Reduce Challenges in the Management of Chronic Rhinosinusitis with Nasal Polyps: The Role of Bio...
1.5 Credits / Immunology
View More
Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Phar...
0.5 Credit / Immunology
View More
Leveraging Biologics and Immunotherapies in the Management of Food Allergies
1.5 Credits / Immunology, Allergy
View More
Reflecting on the Real-World Use of Biologic Therapy in Asthma Management
1.5 Credits / Immunology, Pulmonology
View More
PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices
0.75 Credit / Oncology, Law
View More
Targeting Chronic Rhinosinusitis With Nasal Polyps With Biologics: Optimizing Outcomes and Reducing Health Car...
1.5 Credits / Immunology
View More
Emerging Treatment Options for Inflammatory Bowel Disease: A Focus on IL-23 Pathway Inhibition
1.5 Credits / Gastroenterology, Immunology
View More
Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care...
1.5 Credits / Gastroenterology, Immunology
View More
The Expanding Therapeutic Landscape in IgA Nephropathy: Applying Evidence-Based Strategies and Guideline Updat...
1.0 Credit / Immunology, Nephrology
View More
FDA Approves Expanded Indication for Hyqvia to Treat Pediatric Primary Immunodeficiency
April 12th 2023During the 12-month trial period, Hyqvia was shown to be efficacious treating the occurrence of acute serious bacterial infections in children aged 2 through 16 years with primary immunodeficiency.
Read More
Clinical Overview: Lecanemab for the Treatment of Alzheimer Disease
January 30th 2023Promising results for lecanemab's efficacy in patients with mild cognitive impairment or mild dementia associated with Alzheimer disease were accompanied by reports of adverse effects associated with treatment.
Read More
IVIG, Steroids for Multisystem Inflammatory Syndrome in Children Have Varying Outcomes
November 16th 2022Despite an apparent benefit of intravenous immunoglobulin (IVIG) on early discharge, the likelihood of needing second-line treatment was 3 times higher in patients who initiated treatment with IVIG alone.
Read More
Effective Treatment for Some Patients with Arndt-Gottron Syndrome Can Be Achieved With IVIG
September 1st 2022Though there is no well-defined therapeutic approach to the treatment of Arndt-Gottron syndrome, intravenous immunoglobulins have been documented as a well-tolerated treatment in some cases.
Read More
Study: Metronidazole Desensitization Effectively Treats Patients with Hypersensitivity Reactions
August 1st 2022Patients with past medical histories of immunoglobulin E-mediated hypersensitivity reactions to metronidazole and other antimicrobial agents may receive safe and effective treatment using desensitization protocols.
Read More
Daily Medication Pearl: Privigen Immune Globulin Intravenous (Human)
July 22nd 2022Privigen is indicated for the treatment of primary humoral immunodeficiency, chronic immune thrombocytopenic purpura in patients 15 years of age and older, chronic inflammatory demyelinating polyneuropathy in adults.
Read More